Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Opthea Ltd (OPT)

9.25   -0.1 (-1.07%) 03-07 02:54
Open: 9.42 Pre. Close: 9.35
High: 9.421 Low: 8.98
Volume: 7,581 Market Cap: 397M
Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.44 - 9.497 9.497 - 9.539
Low: 8.848 - 8.921 8.921 - 8.976
Close: 9.152 - 9.262 9.262 - 9.344

Technical analysis

as of: 2021-03-05 5:11:37 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 12.91     One year: 14.41
Support: Support1: 8.98    Support2: 7.47
Resistance: Resistance1: 11.06    Resistance2: 12.34
Pivot: 10.45
Moving Average: MA(5): 9.67     MA(20): 10.63
MA(100):     MA(250):
MACD: MACD(12,26): -0.56     Signal(9): -0.43
Stochastic oscillator: %K(14,3): 17.70     %D(3): 23.83
RSI: RSI(14): 32.57
52-week: High: 14.00  Low: 8.98  Change(%): -24.8
Average Vol(K): 3-Month: 1690  10-Days: 1540

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
OPT has closed above bottom band by 11.5%. Bollinger Bands are 0% narrower than normal.

Headline News

Wed, 24 Feb 2021
Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD - GlobeNewswire

Tue, 20 Oct 2020
Loss-Making Opthea Limited (ASX:OPT) Expected To Breakeven In The Medium-Term - Yahoo Finance

Fri, 16 Oct 2020
Opthea Announces Pricing of Initial Public Offering in the United States - GlobeNewswire

Tue, 13 Oct 2020
Opthea to raise $160M in IPO - Seeking Alpha

Sun, 11 Oct 2020
Opthea Announces Launch of Proposed Initial Public Offering in the United States - GlobeNewswire

Thu, 10 Sep 2020
Opthea Appoints US-Based Non-Executive Director Australian Stock Exchange:OPT.AX - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 42
Shares Float (M) 20
% Held by Insiders
% Held by Institutions 7.16
Shares Short (K) 37
Shares Short P. Month (K) 4

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -29.0
Return on Equity (ttm) -34.5
Qtrly Rev. Growth 0.2
Gross Profit (p.s.) -0.009
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.